BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 17725647)

  • 1. Changing pattern of candidaemia 2001-2006 and use of antifungal therapy at the University Hospital of Vienna, Austria.
    Presterl E; Daxböck F; Graninger W; Willinger B
    Clin Microbiol Infect; 2007 Nov; 13(11):1072-6. PubMed ID: 17725647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management.
    Chen SC; Marriott D; Playford EG; Nguyen Q; Ellis D; Meyer W; Sorrell TC; Slavin M;
    Clin Microbiol Infect; 2009 Jul; 15(7):662-9. PubMed ID: 19614718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of candidaemia and relationship with fluconazole use in an intensive care unit.
    Bassetti M; Ansaldi F; Nicolini L; Malfatto E; Molinari MP; Mussap M; Rebesco B; Bobbio Pallavicini F; Icardi G; Viscoli C
    J Antimicrob Chemother; 2009 Sep; 64(3):625-9. PubMed ID: 19622536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The increased role of non-albicans species in candidaemia: results from a 3-year surveillance study.
    Tan TY; Tan AL; Tee NW; Ng LS; Chee CW
    Mycoses; 2010 Nov; 53(6):515-21. PubMed ID: 19619263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candida glabrata fungaemia in intensive care units.
    Ruan SY; Lee LN; Jerng JS; Yu CJ; Hsueh PR
    Clin Microbiol Infect; 2008 Feb; 14(2):136-40. PubMed ID: 18042196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secular trends in nosocomial candidaemia in non-neutropenic patients in an Italian tertiary hospital.
    Luzzati R; Allegranzi B; Antozzi L; Masala L; Pegoraro E; Azzini A; Concia E
    Clin Microbiol Infect; 2005 Nov; 11(11):908-13. PubMed ID: 16216107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of fluconazole consumption on long-term trends in candidal ecology.
    Blot S; Janssens R; Claeys G; Hoste E; Buyle F; De Waele JJ; Peleman R; Vogelaers D; Vandewoude K
    J Antimicrob Chemother; 2006 Aug; 58(2):474-7. PubMed ID: 16757503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death.
    Slavin MA; Sorrell TC; Marriott D; Thursky KA; Nguyen Q; Ellis DH; Morrissey CO; Chen SC;
    J Antimicrob Chemother; 2010 May; 65(5):1042-51. PubMed ID: 20202987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candida albicans versus non-albicans bloodstream infection in patients in a tertiary hospital: an analysis of microbiological data.
    Samonis G; Kofteridis DP; Saloustros E; Giannopoulou KP; Ntziora F; Christidou A; Maraki S; Falagas ME
    Scand J Infect Dis; 2008; 40(5):414-9. PubMed ID: 18418802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
    Tumbarello M; Sanguinetti M; Trecarichi EM; La Sorda M; Rossi M; de Carolis E; de Gaetano Donati K; Fadda G; Cauda R; Posteraro B
    J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
    Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
    Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of nosocomial candidaemia in a university hospital: a 12-year study.
    Gürcüoğlu E; Ener B; Akalin H; Sinirtaş M; Evci C; Akçağlar S; Yilmaz E; Heper Y
    Epidemiol Infect; 2010 Sep; 138(9):1328-35. PubMed ID: 20056017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal candidaemia in Kuwait: a 12-year study of risk factors, species spectrum and antifungal susceptibility.
    Al-Sweih N; Khan Z; Khan S; Devarajan LV
    Mycoses; 2009 Nov; 52(6):518-23. PubMed ID: 18983425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and outcome for nosocomial breakthrough candidaemia.
    Pasqualotto AC; Nedel WL; Machado TS; Severo LC
    J Infect; 2006 Mar; 52(3):216-22. PubMed ID: 15936825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiological study of invasive nosocomial candidiasis in 2 teaching hospitals in Beijing].
    Cao B; Wang H; Wu L; Sun WJ; Li F; Liu YM
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1970-3. PubMed ID: 19062737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbial profile and drug resistance of Candida strains isolated from the blood of children: an 11-year study.
    Małafiej E; Adamiec AC; Tworzyańska U
    Mycoses; 2009 Mar; 52(2):149-53. PubMed ID: 18627468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use.
    Hope W; Morton A; Eisen DP
    J Hosp Infect; 2002 Jan; 50(1):56-65. PubMed ID: 11825053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candidaemia in an Irish tertiary referral hospital: epidemiology and prognostic factors.
    Boo TW; O'reilly B; O'leary J; Cryan B
    Mycoses; 2005 Jul; 48(4):251-9. PubMed ID: 15982207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nosocomial candidaemia in children: results of a 9-year study.
    Celebi S; Hacimustafaoglu M; Ozdemir O; Ozkaya G
    Mycoses; 2008 May; 51(3):248-57. PubMed ID: 18399906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candida glabrata fungaemia in a tertiary centre in Taiwan: antifungal susceptibility and outcomes.
    Ruan SY; Huang YT; Chu CC; Yu CJ; Hsueh PR
    Int J Antimicrob Agents; 2009 Sep; 34(3):236-9. PubMed ID: 19361960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.